New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A1878

Introduced
1/11/22  

Caption

Requires pharmacies to provide certain information regarding insulin manufacturer assistance programs.

Impact

The implementation of A1878 is expected to significantly affect state laws concerning pharmacy practices and patient rights. By requiring pharmacies to actively inform customers about available assistance programs, the bill emphasizes the role of pharmacies as essential healthcare providers and information hubs. This change aims to alleviate some of the financial burden faced by individuals who rely on insulin for diabetes management, potentially improving health outcomes and accessibility for patients.

Summary

Assembly Bill A1878 aims to enhance patient access to insulin by requiring pharmacies to provide specific information related to insulin manufacturer assistance programs. The bill mandates that pharmacy practice sites display notices concerning these programs at all points of sale and distribute pamphlets to individuals purchasing insulin prescriptions or requesting this information. The intent is to ensure that patients are aware of any assistance available to help manage their insulin costs, addressing a pressing healthcare issue in New Jersey.

Contention

While A1878 is designed to help patients, it may face opposition from some stakeholders concerned about additional burdens imposed on pharmacies. There are discussions around the practical implications of displaying information and distributing pamphlets, with some arguing that it could overwhelm pharmacy operations and staff. However, proponents of the bill argue that the social benefits of informing patients—and potentially lowering their out-of-pocket costs for insulin—outweigh these operational concerns. Additionally, there may be debates regarding the adequacy and accuracy of the information provided through these programs, as well as the responsibilities of insulin manufacturers in assisting pharmacies.

Companion Bills

No companion bills found.

Previously Filed As

NJ A3882

Requires public schools to post link to subsidized school meals application, and certain informational videos related to application, in prominent place on Internet website.

NJ A2123

Requires public institution of higher education to provide students with information on food assistance programs.

NJ A1785

Establishes insulin assistance program.

NJ A1510

Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.*

NJ A588

Requires public community water systems to provide customers with certain information regarding lead in drinking water.

NJ HF3756

Definition for covered insulin provided for the insulin safety net program and manufacturer registration fee.

NJ H0385

Adds to existing law to establish provisions regarding certain prohibited actions by pharmaceutical manufacturers.

NJ SB2024

Pharmaceutical products; requiring publishing of certain information by manufacturers. Effective date.

NJ A3357

Requires MVC to provide certain services at each MVC agency location and to make available certain informational brochures.

NJ A2199

Requires child abuse reporting hotline maintained by DCPP to provide information on resources available to victims and families.

Similar Bills

NJ A1593

Establishes certain protocols for prescribing and dispensing benzodiazepine.

NJ A1363

Requires DHS to take action to raise public awareness of privacy laws that prevent disclosure of health care enrollment information to immigration authorities.

NJ A1502

"Patient and Provider Protection Act."

UT HB0257

Opiate Information Amendments

NJ A3305

Requires certain consumer disclosures relating to rabies testing and establishes optional training for veterinarians.

NJ A3920

Provides for notification to new residents regarding banned weapons.

NJ A1332

Directs BPU to establish public information campaign concerning public utility meter inspection and calibration.

MS HB1572

Rare Disease Task Force; create within the MS Rare Disease Advisory Council.